期刊文献+

HAART早期AIDS患者CD4^+CD25^+Foxp3^+调节性T细胞的变化及其与免疫活化关系的研究 被引量:2

Relationship between CD4^+ CD25^+ Foxp3^+ Regulatory T Cells and Immune Activation in AIDS Patients Undergoing Early Highly Active Anti-retroviral Therapy
下载PDF
导出
摘要 目的了解高效抗反转录病毒联合疗法(highly active antiretroviral the rapy,HAART)早期AIDS患者CD4+CD25+Foxp3+调节性T细胞(regulatory Tcell,Treg)的变化规律,探讨抗病毒治疗过程中Treg细胞的作用。方法前瞻性分析21例接受HAART规律治疗的AIDS患者,收集患者服药前及服药第2、4、8、12周时的静脉血,采用流式细胞仪胞内染色技术检测CD4+CD25+Foxp3+调节性T细胞的水平,分析Treg细胞在治疗过程中的变化规律,以及Treg细胞的变化与免疫活化间的相关性。结果 HAART治疗开始,Treg细胞计数呈逐渐上升的趋势,前4周呈现快速上升,而后上升速度减慢,Treg百分比变化也有相似的规律;CD8+CD38+表达水平随治疗时间延长而下降,未治疗时Treg细胞计数与免疫活化水平呈负相关,治疗后Treg细胞计数4周内的变化与12周CD8+CD38+水平呈负相关,即治疗开始后,前4周内Treg细胞增加越明显,治疗3个月时免疫活化水平下降越明显。结论抗病毒治疗过程中,活化CD8+淋巴细胞比例的下降与外周血中Treg细胞数的增加相关。Treg细胞数量恢复越早,活化CD8+淋巴细胞比例下降越明显。 Objective To understand the variation of the CD4+CD25+Foxp3+ regulatory T cells in HIV-infected patients during early highly active anti-retroviral therapy(HAART) and the function of Treg cells during antiviral therapy.Methods Data of 21 HIV-infected patients undergoing HAART were analyzed in this study.This was a prospective study which enrolled treatment-naive HIV-infected patients just prior to starting HAART;levels of Treg were measured by flow cytometry at weeks 0,2,4,8,12 of treatment.The relationship between Treg cells and immunologic activation was studied.Results Treg cell counts were higher when treatment with HAART was started,especially during first 4 weeks,then the trend was slowed down,so was the ratio of Treg.As HAART went on,the expression of CD8+CD38+ was reduced.The Treg counts was inversely correlated with immune activation level for treatment-naive patients.Conclusion The declined ratio of activated CD8+ may be related to the number of elevated Treg cells.The earlier the Treg cells resumed,the more the proportion of activated CD8+ T cells declined.
出处 《首都医科大学学报》 CAS 北大核心 2010年第6期701-705,共5页 Journal of Capital Medical University
基金 国家"十一五"传染病重大专项(2008ZX10001-006) 北京市科委资助项目(D0906003040391)~~
关键词 调节性T细胞 人类免疫缺陷病毒 高效抗反转录病毒治疗 regulatory T cells human immunodeficiency virus highly active anti-retroviral therapy
  • 相关文献

参考文献9

  • 1Aandahl E M,Michalsson J,Moretto W J,et al.Human CD4^+ CD25^+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens[J].J Virol,2004,78:2454-2459.
  • 2Kinter A L,Hennessey M,Bell A,et al.CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status[J].J Exp Med,2004,2;200:331-343.
  • 3Hazenberg M D,Otto S A,van Benthem B H,et al.Persistent immune activation in HIV-1 infection is associated with progression to AIDS[J].AIDS,2003,17:1881-1888.
  • 4Autran B,Carcelain G,Li T S,et al.Positive effects of combined antiretroviral therapy on CD4+T cell homeostasis and function in advanced HIV disease[J].Science,1997,277:112-116.
  • 5Bouscarat F,Levacher-Clergeot M,Dazza M C,et al.Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1[J].AIDS Res Hum Retroviruses,1996,12:17-24.
  • 6Jiao Y,Fu J,Xing S,et al.The decrease of regulatory T cells correlates with excessive activation and apoptosis of CD8+ T cells in HIV-1-infected typical progressors,but not in long-term non-progressors[J].Immunology,2009,128(1 suppl):e366-375.
  • 7Vollbrecht T,Brackmann H,Henrich N,et al.Impact of changes in antigen level on CD38/PD-1 co-expression on HIV-specific CD8 T cells in chronic,untreated HIV-1 infection[J].J Med Virol,2010,82:358-370.
  • 8Bouscarat F,Levacher M,Landman R,et al.Changes in blood CD8+ lymphocyte activation status and plasma HIV RNA levels during antiretroviral therapy[J].AIDS,1998,12:1267-1273.
  • 9Kinter A L,Hennessey M,Bell A,et al.CD25^+ CD4^+ regulatory T-cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4^+ and CD8+ HIV-specific T-cell immune responses in vitro and are associated with favorable clinical markers of disease status[J].J Exp Med,2004,200:331-343.

同被引文献30

  • 1田慧,张奇.T细胞基因治疗艾滋病的研究进展[J].中国药房,2011,22(6):552-554. 被引量:2
  • 2韦雪芳.艾滋病检测技术研究进展[J].应用预防医学,2010,16(S1):23-26. 被引量:1
  • 3王文川,杨志云,毛羽,李峰,王玉光,赵红心.中医药治疗艾滋病的研究进展[J].时珍国医国药,2010,21(12):3258-3259. 被引量:3
  • 4王小平.运用三焦辨证论治艾滋病的探讨[J].山东中医杂志,2007,26(2):80-82. 被引量:13
  • 5胡研萍,王健.艾滋病从瘀论治探讨[J].辽宁中医杂志,2007,34(4):417-419. 被引量:12
  • 6Orendi J M,Bloem A C,Borleffs J C,et al.Activation and cell cycle antigens in CD4+and CD8+T cells correlate withplasma human immunodeficiency virus(HIV-1) RNA level in HIV-1 infection[J].J Infect Dis,1998,178:1279-1287.
  • 7Sousa A E,Carneiro J,Meier-Schellersheim M,et al.CD4+ T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load[J].J Immunol,2002,169:3400-3406.
  • 8Hazenberg M D,Otto S A,van Benthem B H,et al.Persistent immune activation in HIV-1 infection is associated with progression to AIDS[J].AIDS,2003,17:1881-1888.
  • 9Jiao Y,Fu J,Xing S,et al.The decrease of regulatory T cells correlates with excessive activation and apoptosis of CD8(+) T cells in HIV-1-infected typical progressors,but not in long-term non-progressors[J].Immunology,2009,128:e366-375.
  • 10Sempere J M,Soriano V,Benito J M.T regulatory cells and HIV infection[J].AIDS Rev,2007,9:54-60.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部